Order Article Reprints

Bega G, Olivieri J, Riva M, Scapinello G, Paolini R, Finotto S, Sartori R, Lucchini E, Guandalini G, Facchinelli D, et al. Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma. Cancers. 2021; 13(23):6089. https://doi.org/10.3390/cancers13236089

Bega, Giulia, Jacopo Olivieri, Marcello Riva, Greta Scapinello, Rossella Paolini, Silvia Finotto, Roberto Sartori, Elisa Lucchini, Gianmarco Guandalini, Davide Facchinelli, and et al. 2021. "Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma" Cancers 13, no. 23: 6089. https://doi.org/10.3390/cancers13236089

Bega, G., Olivieri, J., Riva, M., Scapinello, G., Paolini, R., Finotto, S., Sartori, R., Lucchini, E., Guandalini, G., Facchinelli, D., Tisi, M. C., Basso, M., Ballotta, L., Piazza, F., Ferrarini, I., & Visco, C. (2021). Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma. Cancers, 13(23), 6089. https://doi.org/10.3390/cancers13236089